Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EQTSE:RAY.BCVE:SAT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEQEquillium$0.41+2.5%$0.48$0.34▼$1.53$14.50M2.06358,769 shs37,129 shsRAY.BStingray GroupC$8.46-3.4%C$7.97C$6.12▼C$9.63C$19.80M1.07910 shs400 shsSATAsian Television Network InternationalC$0.10C$0.09C$0.07▼C$0.17C$2.44M1.5218,501 shs13,000 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEQEquillium0.00%+8.56%-13.62%-53.86%-71.61%RAY.BStingray Group0.00%-3.42%+21.73%-8.54%+13.40%SATAsian Television Network International0.00%0.00%+25.00%-4.76%-9.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEQEquillium2.6768 of 5 stars3.25.00.00.02.21.70.6RAY.BStingray GroupN/AN/AN/AN/AN/AN/AN/AN/ASATAsian Television Network InternationalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEQEquillium 2.33Hold$3.00638.92% UpsideRAY.BStingray Group 0.00N/AN/AN/ASATAsian Television Network International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RAY.B, SAT, and EQ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/28/2025EQEquilliumLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/28/2025EQEquilliumLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$3.00 ➝ $1.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEQEquillium$30.41M0.48N/AN/A$0.64 per share0.63RAY.BStingray GroupC$355.51M0.06C$0.40 per share21.04C$3.72 per share2.27SATAsian Television Network InternationalC$7.27M0.34C$0.01 per share8.75C($0.03) per share-3.33Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEQEquillium-$13.34M-$0.39N/AN/AN/A-10.05%-20.68%-10.77%8/6/2025 (Estimated)RAY.BStingray Group-C$20.56M-C$0.29N/A∞N/A-5.78%-7.45%6.63%N/ASATAsian Television Network International-C$1.96M-C$0.08N/A∞N/A-26.90%-736.52%-17.56%N/ALatest RAY.B, SAT, and EQ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/27/2025Q4 2024EQEquillium-$0.22-$0.16+$0.06-$0.16N/A$4.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEQEquilliumN/AN/AN/AN/AN/ARAY.BStingray GroupC$0.303.55%N/AN/A N/ASATAsian Television Network InternationalC$0.0220.00%N/AN/A N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEQEquilliumN/A3.043.04RAY.BStingray Group154.451.050.69SATAsian Television Network International10,844.680.590.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEQEquillium27.05%RAY.BStingray GroupN/ASATAsian Television Network InternationalN/AInsider OwnershipCompanyInsider OwnershipEQEquillium31.60%RAY.BStingray GroupN/ASATAsian Television Network International77.44%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEQEquillium4035.72 million24.70 millionNot OptionableRAY.BStingray Group1,0002.34 millionN/ANot OptionableSATAsian Television Network InternationalN/A24.40 millionN/ANot OptionableRAY.B, SAT, and EQ HeadlinesRecent News About These CompaniesATN expands largest channel lineup in Western CanadaMay 13, 2025 | tmcnet.comATN launches 3 ZEE channels exclusively in CanadaApril 23, 2025 | newswire.caATN - Asian Television Network celebrates 25 Years on the TSX Venture Exchange (TSXV)April 8, 2025 | theglobeandmail.comAsian Television Network International Third Quarter 2024 Earnings: CA$0.005 loss per share (vs CA$0.004 profit in 3Q 2023)November 28, 2024 | finance.yahoo.comATN acquires exclusive Broadcast rights for New Zealand Cricket for 3 yearsNovember 27, 2024 | ca.finance.yahoo.comAsian Television Network International LtdNovember 18, 2024 | investing.comTelecom M&A: DirecTV-Dish Deal In Peril. Charter To Buy Liberty Broadband.November 14, 2024 | yahoo.comDirecTV said it plans to abandon its Dish mergerNovember 13, 2024 | edition.cnn.comAustralia scraps multibillion dollar military satellite projectNovember 6, 2024 | scmp.comSpaceX pushes Taiwanese suppliers to expand abroad: Details hereNovember 6, 2024 | msn.comIsrael has long wanted to dismantle the UN’s Palestinian refugee agency. The consequences could be disastrous for allNovember 4, 2024 | cnn.comPulsar launches “Pulsar Community” for ship-shore team collaborationOctober 30, 2024 | thedigitalship.com‘Mysterious failures’ rock tech giant Boeing as satellite explodes in spaceOctober 27, 2024 | news.com.auCustomers express frustration as channels disappear on Multichoice’s GoTvOctober 25, 2024 | technext24.comChina, Brazil hold satellite collaboration talksOctober 21, 2024 | advanced-television.comIndia backs Musk in satellite spectrum allocation rowOctober 17, 2024 | techcrunch.comMax Confirmed to Launch in Seven Asian Territories in NovemberOctober 15, 2024 | msn.comFloods, blackouts and gas shortages: Florida faces headwinds in the wake of hurricanes Helene and MiltonOctober 12, 2024 | msn.comQ2 2025 VOXX International Corp Earnings CallOctober 12, 2024 | finance.yahoo.comUnivision says it will not live fact check candidates during Harris, Trump town hallsOctober 11, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRAY.B, SAT, and EQ Company DescriptionsEquillium NASDAQ:EQ$0.41 +0.01 (+2.53%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.43 +0.03 (+6.90%) As of 05/23/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.Stingray Group TSE:RAY.BC$8.46 -0.30 (-3.42%) As of 05/23/2025 01:32 PM EasternStingray Group Inc is a music, media, and technology company. The company is a provider of curated direct-to-consumer and B2B services, including audio television channels, radio stations, SVOD content, 4K UHD television channels, karaoke products, digital signage, in-store music, and music apps. It operates through the following segments namely the Broadcasting and commercial music segment and Radio segment. The company generates maximum revenue from the Broadcasting and commercial music segment.Asian Television Network International CVE:SATC$0.10 0.00 (0.00%) As of 05/21/2025 02:45 PM EasternAsian Television Network International Limited engages in the specialty, pay television broadcasting, and advertising primarily for the south Asian community in Canada. It operates premium pay specialty television channels in 9 languages. The company provides its flagship ATN-HD general interest service; and various Bollywood movie channels with approximately 100 movies a month, as well as various channels that include sports, news, music, lifestyle, spiritual, and regional language channels. It also operates a South Asian radio service on satellite radio in the United States and Canada. The company offers its channels on various cable, satellite, and IPTV platforms. Asian Television Network International Limited was founded in 1971 and is based in Markham, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
